New directions in poly(ADP-ribose) polymerase biology

被引:61
|
作者
Bock, Florian J. [1 ,2 ]
Chang, Paul [3 ]
机构
[1] Canc Res UK Beatson Inst, Garscube Estate, Glasgow, Lanark, Scotland
[2] Univ Glasgow, Inst Canc Sci, Garscube Estate, Glasgow, Lanark, Scotland
[3] Ribon Therapeut, Lexington, MA 02421 USA
关键词
ADP-ribosylation; poly(ADP-ribose) polymerases; post-translational modification; stress response; NF-KAPPA-B; ADP-RIBOSYLTRANSFERASE ARTD10; PROTEOME-WIDE IDENTIFICATION; DNA STRAND BREAKS; RNA REGULATION; STRESS RESPONSES; MAMMALIAN-CELLS; ES CELLS; T-CELLS; RIBOSE;
D O I
10.1111/febs.13737
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Poly(ADP-ribose) polymerases (PARPs) regulate the function of target proteins by modifying them with ADP-ribose, a large and unique post-translational modification. Humans express 17 PARPs; however, historically, much of the focus has been on PARP1 and its function in DNA damage repair. Recent work has uncovered an amazing diversity of function for these enzymes including the regulation of fundamental physiological processes in the cell and at the organismal level, as well as new roles in regulating cellular stress responses. In this review, we discuss recent advancements in our understanding of this important protein family, and technological developments that have been critical for moving the field forward. Finally, we discuss new directions that we feel are important areas of further scientific exploration.
引用
收藏
页码:4017 / 4031
页数:15
相关论文
共 50 条
  • [1] New inhibitors of poly(ADP-ribose) polymerase (PARP)
    Peukert, S
    Schwahn, U
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (11) : 1531 - 1551
  • [2] Poly(ADP-ribose) polymerase: a new therapeutic target?
    Geroe, Domokos
    Szabo, Csaba
    CURRENT OPINION IN ANESTHESIOLOGY, 2008, 21 (02) : 111 - 121
  • [3] Current status of poly(ADP-ribose) polymerase inhibitors and future directions
    Ohmoto, Akihiro
    Yachida, Shinichi
    ONCOTARGETS AND THERAPY, 2017, 10 : 5195 - 5208
  • [4] POLY(ADP-RIBOSE) POLYMERASE AND DNA
    YOSHIHARA, K
    SEIKAGAKU, 1981, 53 (07): : 528 - 534
  • [5] Poly(ADP-Ribose) Polymerase Inhibitors
    Garon, Edward B.
    Dubnett, Steven M.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S455 - S456
  • [6] Poly(ADP-ribose) polymerase and aging
    Burkle, A
    EXPERIMENTAL GERONTOLOGY, 1998, 33 (06) : 519 - 523
  • [7] Trapping Poly(ADP-Ribose) Polymerase
    Shen, Yuqiao
    Aoyagi-Scharber, Mika
    Wang, Bing
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2015, 353 (03): : 446 - 457
  • [8] Poly(ADP-ribose) polymerase inhibitors
    Southan, GJ
    Szabó, C
    CURRENT MEDICINAL CHEMISTRY, 2003, 10 (04) : 321 - 340
  • [9] Current role of poly(ADP-ribose) polymerase inhibitors: which poly(ADP-ribose) polymerase inhibitor and when?
    Vanacker, Helene
    Romeo, Clemence
    Ray-Coquard, Isabelle
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (05) : 394 - 403
  • [10] POLY(ADP-RIBOSE) POLYMERASE-ACTIVITY AND POLY(ADP-RIBOSE) LEVELS AS A FUNCTION OF GROWTH
    LEVI, V
    JUAREZSALINAS, H
    FEDERATION PROCEEDINGS, 1980, 39 (06) : 2007 - 2007